AxoGen (AXGN) Competitors $16.46 -0.34 (-1.99%) As of 01:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AXGN vs. WRBY, INSP, LQDA, PRCT, LMAT, AORT, EYE, ENOV, CNMD, and NVCRShould you be buying AxoGen stock or one of its competitors? The main competitors of AxoGen include Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), National Vision (EYE), Enovis (ENOV), CONMED (CNMD), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry. AxoGen vs. Its Competitors Warby Parker Inspire Medical Systems Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion National Vision Enovis CONMED NovoCure Warby Parker (NYSE:WRBY) and AxoGen (NASDAQ:AXGN) are both medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk. Do institutionals and insiders have more ownership in WRBY or AXGN? 93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 18.2% of Warby Parker shares are owned by insiders. Comparatively, 2.8% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, WRBY or AXGN? AxoGen has lower revenue, but higher earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than AxoGen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$771.32M3.67-$20.39M-$0.07-384.64AxoGen$203.27M3.73-$9.96M-$0.10-164.65 Do analysts rate WRBY or AXGN? Warby Parker currently has a consensus price target of $24.06, suggesting a potential downside of 10.63%. AxoGen has a consensus price target of $26.00, suggesting a potential upside of 57.91%. Given AxoGen's stronger consensus rating and higher possible upside, analysts clearly believe AxoGen is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 9 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.55AxoGen 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is WRBY or AXGN more profitable? Warby Parker has a net margin of -1.12% compared to AxoGen's net margin of -2.29%. Warby Parker's return on equity of -0.79% beat AxoGen's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-1.12% -0.79% -0.41% AxoGen -2.29%-4.43%-2.34% Which has more risk and volatility, WRBY or AXGN? Warby Parker has a beta of 2.1, suggesting that its share price is 110% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Does the media prefer WRBY or AXGN? In the previous week, Warby Parker had 6 more articles in the media than AxoGen. MarketBeat recorded 15 mentions for Warby Parker and 9 mentions for AxoGen. AxoGen's average media sentiment score of 1.26 beat Warby Parker's score of 1.19 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 10 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive AxoGen 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryWarby Parker beats AxoGen on 10 of the 16 factors compared between the two stocks. Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AXGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AXGN vs. The Competition Export to ExcelMetricAxoGenMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$758.02M$6.72B$5.80B$10.16BDividend YieldN/A1.23%5.69%4.61%P/E Ratio-164.7226.0074.6226.00Price / Sales3.7363.48468.1791.50Price / CashN/A21.6337.0859.91Price / Book6.984.9912.156.30Net Income-$9.96M$176.38M$3.28B$270.75M7 Day Performance3.04%1.04%1.13%3.33%1 Month Performance16.28%3.25%7.44%6.49%1 Year Performance21.33%12.41%63.14%28.08% AxoGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AXGNAxoGen2.9081 of 5 stars$16.47-2.0%$26.00+57.9%+26.5%$758.02M$203.27M-164.72450Positive NewsWRBYWarby Parker1.6999 of 5 stars$26.74+2.8%$24.06-10.0%+96.3%$2.74B$771.32M-382.003,780Positive NewsInsider TradeINSPInspire Medical Systems4.9064 of 5 stars$83.51-3.4%$164.50+97.0%-60.0%$2.56B$802.80M48.271,246Positive NewsLQDALiquidia Technologies3.7624 of 5 stars$27.98-3.0%$32.11+14.8%+166.0%$2.48B$14M-16.4650Positive NewsPRCTPROCEPT BioRobotics3.2385 of 5 stars$38.92-4.3%$73.22+88.1%-50.5%$2.26B$224.50M-25.11430Positive NewsLMATLeMaitre Vascular3.0639 of 5 stars$97.07-0.4%$97.60+0.5%+8.6%$2.21B$219.86M47.12490Positive NewsAORTArtivion2.7507 of 5 stars$43.34-0.3%$40.63-6.2%+73.7%$2.05B$388.54M-103.191,600Positive NewsEYENational Vision2.7483 of 5 stars$23.08-1.7%$24.73+7.1%+126.7%$1.86B$1.82B-128.2213,411Positive NewsENOVEnovis4.0637 of 5 stars$31.39-2.3%$51.00+62.5%-26.7%$1.84B$2.11B-2.207,367Positive NewsInsider TradeGap UpCNMDCONMED4.0908 of 5 stars$53.78-2.2%$59.80+11.2%-26.4%$1.70B$1.31B15.233,900NVCRNovoCure4.3902 of 5 stars$12.60+2.6%$28.79+128.5%-26.1%$1.37B$605.22M-8.081,488Positive News Related Companies and Tools Related Companies WRBY Alternatives INSP Alternatives LQDA Alternatives PRCT Alternatives LMAT Alternatives AORT Alternatives EYE Alternatives ENOV Alternatives CNMD Alternatives NVCR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AXGN) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AXGN Stock Alerts